Insider Selling: Doximity (NASDAQ:DOCS) Director Sells $132,880.00 in Stock

Doximity, Inc. (NASDAQ:DOCS) Director Kira Scherer Wampler sold 2,000 shares of the firm’s stock in a transaction that occurred on Monday, November 3rd. The shares were sold at an average price of $66.44, for a total transaction of $132,880.00. Following the transaction, the director directly owned 19,839 shares in the company, valued at approximately $1,318,103.16. The trade was a 9.16% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Doximity Price Performance

Doximity stock opened at $54.20 on Friday. Doximity, Inc. has a fifty-two week low of $47.66 and a fifty-two week high of $85.21. The firm has a market cap of $10.15 billion, a price-to-earnings ratio of 54.20, a P/E/G ratio of 4.10 and a beta of 1.36. The firm has a fifty day moving average price of $69.27 and a two-hundred day moving average price of $62.61.

Doximity (NASDAQ:DOCS) last released its earnings results on Thursday, November 6th. The company reported $0.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.38 by $0.07. Doximity had a return on equity of 21.75% and a net margin of 36.60%.During the same period last year, the company posted $0.30 EPS. Doximity’s revenue was up 23.2% on a year-over-year basis. Doximity has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. As a group, sell-side analysts expect that Doximity, Inc. will post 0.99 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Voya Investment Management LLC boosted its holdings in Doximity by 932.8% during the third quarter. Voya Investment Management LLC now owns 1,567,668 shares of the company’s stock valued at $114,267,000 after purchasing an additional 1,415,882 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in shares of Doximity by 130.4% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,966,801 shares of the company’s stock worth $114,133,000 after buying an additional 1,113,076 shares during the period. Franklin Resources Inc. boosted its stake in Doximity by 53.9% in the 2nd quarter. Franklin Resources Inc. now owns 3,162,593 shares of the company’s stock valued at $193,993,000 after buying an additional 1,108,162 shares in the last quarter. Vanguard Group Inc. boosted its stake in Doximity by 8.8% in the 1st quarter. Vanguard Group Inc. now owns 12,194,492 shares of the company’s stock valued at $707,646,000 after buying an additional 990,923 shares in the last quarter. Finally, Holocene Advisors LP bought a new stake in Doximity in the second quarter valued at $44,983,000. Institutional investors and hedge funds own 87.19% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently commented on DOCS. The Goldman Sachs Group set a $64.00 target price on shares of Doximity and gave the company a “sell” rating in a research note on Wednesday, October 1st. Needham & Company LLC upped their price objective on shares of Doximity from $67.00 to $75.00 and gave the company a “buy” rating in a research report on Friday, August 8th. Wells Fargo & Company lifted their target price on Doximity from $55.00 to $62.00 and gave the stock an “equal weight” rating in a research report on Monday, August 4th. Canaccord Genuity Group boosted their price target on Doximity from $59.00 to $67.00 and gave the company a “hold” rating in a research note on Thursday, September 18th. Finally, Robert W. Baird raised their price objective on Doximity from $75.00 to $80.00 and gave the stock an “outperform” rating in a research report on Thursday, September 11th. One investment analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, eight have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $69.84.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.